位置:首页 > 蛋白库 > DHI1_RABIT
DHI1_RABIT
ID   DHI1_RABIT              Reviewed;         292 AA.
AC   Q7M3I4;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-AUG-2022, entry version 95.
DE   RecName: Full=11-beta-hydroxysteroid dehydrogenase 1 {ECO:0000303|PubMed:7836463};
DE            Short=11-DH {ECO:0000303|PubMed:7836463};
DE            Short=11-beta-HSD1 {ECO:0000303|PubMed:19456256};
DE            EC=1.1.1.146 {ECO:0000269|PubMed:19456256, ECO:0000269|PubMed:7836463};
DE   AltName: Full=7-oxosteroid reductase;
DE            EC=1.1.1.201 {ECO:0000250|UniProtKB:P28845};
DE   AltName: Full=Corticosteroid 11-beta-dehydrogenase isozyme 1;
GN   Name=HSD11B1 {ECO:0000250|UniProtKB:P28845};
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1] {ECO:0000305, ECO:0000312|PIR:A55573}
RP   PROTEIN SEQUENCE OF 2-292, FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, DISULFIDE BOND, AND GLYCOSYLATION AT ASN-123; ASN-162 AND
RP   ASN-207.
RC   STRAIN=New Zealand {ECO:0000269|PubMed:7836463};
RC   TISSUE=Liver {ECO:0000269|PubMed:7836463};
RX   PubMed=7836463; DOI=10.1074/jbc.270.5.2305;
RA   Ozols J.;
RT   "Lumenal orientation and post-translational modifications of the liver
RT   microsomal 11beta-hydroxysteroid dehydrogenase.";
RL   J. Biol. Chem. 270:2305-2312(1995).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=19456256; DOI=10.1089/jop.2008.0120;
RA   Anderson S., Carreiro S., Quenzer T., Gale D., Xiang C., Gukasyan H.,
RA   Lafontaine J., Cheng H., Krauss A., Prasanna G.;
RT   "In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the
RT   rabbit eye.";
RL   J. Ocul. Pharmacol. Ther. 25:215-222(2009).
CC   -!- FUNCTION: Controls the reversible conversion of biologically active
CC       glucocorticoids such as cortisone to cortisol, and 11-
CC       dehydrocorticosterone to corticosterone in the presence of NADP(H)
CC       (PubMed:7836463, PubMed:19456256). Participates in the corticosteroid
CC       receptor-mediated anti-inflammatory response, as well as metabolic and
CC       homeostatic processes (By similarity). Plays a role in the secretion of
CC       aqueous humor in the eye, maintaining a normotensive, intraocular
CC       environment (By similarity). Bidirectional in vitro, predominantly
CC       functions as a reductase in vivo, thereby increasing the concentration
CC       of active glucocorticoids (By similarity). It has broad substrate
CC       specificity, besides glucocorticoids, it accepts other steroid and
CC       sterol substrates. It has broad substrate specificity, besides
CC       glucocorticoids, it accepts other steroid and sterol substrates.
CC       Interconverts 7-oxo- and 7-hydroxy-neurosteroids such as 7-
CC       oxopregnenolone and 7beta-hydroxypregnenolone, 7-
CC       oxodehydroepiandrosterone (3beta-hydroxy-5-androstene-7,17-dione) and
CC       7beta-hydroxydehydroepiandrosterone (3beta,7beta-dihydroxyandrost-5-en-
CC       17-one), among others (By similarity). Catalyzes the stereo-specific
CC       conversion of the major dietary oxysterol, 7-ketocholesterol (7-
CC       oxocholesterol), into the more polar 7-beta-hydroxycholesterol
CC       metabolite (By similarity). 7-oxocholesterol is one of the most
CC       important oxysterols, it participates in several events such as
CC       induction of apoptosis, accumulation in atherosclerotic lesions, lipid
CC       peroxidation, and induction of foam cell formation (By similarity).
CC       Mediates the 7-oxo reduction of 7-oxolithocholate mainly to
CC       chenodeoxycholate, and to a lesser extent to ursodeoxycholate, both in
CC       its free form and when conjugated to glycine or taurine, providing a
CC       link between glucocorticoid activation and bile acid metabolism (By
CC       similarity). Catalyzes the synthesis of 7-beta-25-dihydroxycholesterol
CC       from 7-oxo-25-hydroxycholesterol in vitro, which acts as ligand for the
CC       G-protein-coupled receptor (GPCR) Epstein-Barr virus-induced gene 2
CC       (EBI2) and may thereby regulate immune cell migration (By similarity).
CC       {ECO:0000250|UniProtKB:P28845, ECO:0000250|UniProtKB:P50172,
CC       ECO:0000269|PubMed:19456256, ECO:0000269|PubMed:7836463}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an 11beta-hydroxysteroid + NADP(+) = an 11-oxosteroid + H(+) +
CC         NADPH; Xref=Rhea:RHEA:11388, ChEBI:CHEBI:15378, ChEBI:CHEBI:35346,
CC         ChEBI:CHEBI:47787, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.146; Evidence={ECO:0000269|PubMed:19456256,
CC         ECO:0000269|PubMed:7836463};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11389;
CC         Evidence={ECO:0000305|PubMed:19456256, ECO:0000305|PubMed:7836463};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:11390;
CC         Evidence={ECO:0000269|PubMed:19456256, ECO:0000269|PubMed:7836463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=corticosterone + NADP(+) = 11-dehydrocorticosterone + H(+) +
CC         NADPH; Xref=Rhea:RHEA:42200, ChEBI:CHEBI:15378, ChEBI:CHEBI:16827,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78600;
CC         Evidence={ECO:0000269|PubMed:7836463};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42201;
CC         Evidence={ECO:0000269|PubMed:7836463};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:42202;
CC         Evidence={ECO:0000305|PubMed:7836463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cortisone + H(+) + NADPH = cortisol + NADP(+);
CC         Xref=Rhea:RHEA:68616, ChEBI:CHEBI:15378, ChEBI:CHEBI:16962,
CC         ChEBI:CHEBI:17650, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000269|PubMed:19456256};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68617;
CC         Evidence={ECO:0000269|PubMed:19456256};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:68618;
CC         Evidence={ECO:0000305|PubMed:19456256};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 7beta-hydroxysteroid + NADP(+) = a 7-oxosteroid + H(+) +
CC         NADPH; Xref=Rhea:RHEA:20233, ChEBI:CHEBI:15378, ChEBI:CHEBI:35349,
CC         ChEBI:CHEBI:47789, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.201; Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:20235;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7-oxocholesterol + H(+) + NADPH = 7beta-hydroxycholesterol +
CC         NADP(+); Xref=Rhea:RHEA:68656, ChEBI:CHEBI:15378, ChEBI:CHEBI:42989,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:64294;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68657;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chenodeoxycholate + NADP(+) = 7-oxolithocholate + H(+) +
CC         NADPH; Xref=Rhea:RHEA:53820, ChEBI:CHEBI:15378, ChEBI:CHEBI:36234,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78605;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:53822;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7-oxolithocholate + H(+) + NADPH = NADP(+) + ursodeoxycholate;
CC         Xref=Rhea:RHEA:47540, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78604, ChEBI:CHEBI:78605;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47541;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycochenodeoxycholate + NADP(+) = 7-oxoglycolithocholate +
CC         H(+) + NADPH; Xref=Rhea:RHEA:65056, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:36252, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:137818; Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:65058;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + taurochenodeoxycholate = 7-oxotaurolithocholate +
CC         H(+) + NADPH; Xref=Rhea:RHEA:65060, ChEBI:CHEBI:9407,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:137724; Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:65062;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + tauroursodeoxycholate = 7-oxotaurolithocholate +
CC         H(+) + NADPH; Xref=Rhea:RHEA:68980, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132028,
CC         ChEBI:CHEBI:137724; Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:68982;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycoursodeoxycholate + NADP(+) = 7-oxoglycolithocholate +
CC         H(+) + NADPH; Xref=Rhea:RHEA:68976, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132030,
CC         ChEBI:CHEBI:137818; Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:68978;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7-oxopregnenolone + H(+) + NADPH = 7beta-hydroxypregnenolone +
CC         NADP(+); Xref=Rhea:RHEA:69436, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:183806, ChEBI:CHEBI:183807;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69437;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3beta,7alpha-dihydroxyandrost-5-en-17-one + NADP(+) = 3beta-
CC         hydroxy-5-androstene-7,17-dione + H(+) + NADPH; Xref=Rhea:RHEA:69440,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:81471, ChEBI:CHEBI:183808;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69441;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3beta-hydroxy-5-androstene-7,17-dione + H(+) + NADPH =
CC         3beta,7beta-dihydroxyandrost-5-en-17-one + NADP(+);
CC         Xref=Rhea:RHEA:69452, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:183368, ChEBI:CHEBI:183808;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69453;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3beta-hydroxy-5alpha-androstane-7,17-dione + H(+) + NADPH =
CC         3beta,7beta-dihydroxy-5alpha-androstan-17-one + NADP(+);
CC         Xref=Rhea:RHEA:69456, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:79834, ChEBI:CHEBI:183809;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69457;
CC         Evidence={ECO:0000250|UniProtKB:P28845};
CC   -!- PATHWAY: Steroid metabolism. {ECO:0000250|UniProtKB:P28845}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P28845}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:7836463}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:7836463}. Microsome membrane
CC       {ECO:0000269|PubMed:7836463}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:7836463}.
CC   -!- TISSUE SPECIFICITY: Expressed in the eye.
CC       {ECO:0000269|PubMed:19456256}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:7836463}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   PIR; A55573; A55573.
DR   AlphaFoldDB; Q7M3I4; -.
DR   SMR; Q7M3I4; -.
DR   STRING; 9986.ENSOCUP00000003489; -.
DR   iPTMnet; Q7M3I4; -.
DR   eggNOG; KOG1205; Eukaryota.
DR   InParanoid; Q7M3I4; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0070524; F:11-beta-hydroxysteroid dehydrogenase (NADP+) activity; IDA:GO_Central.
DR   GO; GO:0047022; F:7-beta-hydroxysteroid dehydrogenase (NADP+) activity; IEA:RHEA.
DR   GO; GO:0102196; F:cortisol dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008202; P:steroid metabolic process; IEA:UniProtKB-KW.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Endoplasmic reticulum; Glycoprotein;
KW   Lipid metabolism; Membrane; Microsome; NADP; Oxidoreductase;
KW   Reference proteome; Signal-anchor; Steroid metabolism; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7836463"
FT   CHAIN           2..292
FT                   /note="11-beta-hydroxysteroid dehydrogenase 1"
FT                   /id="PRO_0000054622"
FT   TOPO_DOM        2..7
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        8..24
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        25..292
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        183
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT   BINDING         41..67
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT   BINDING         92..93
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT   BINDING         119..121
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT   BINDING         170
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         183..187
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT   BINDING         218..222
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P28845"
FT   CARBOHYD        123
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:7836463"
FT   CARBOHYD        162
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:7836463"
FT   CARBOHYD        207
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:7836463"
SQ   SEQUENCE   292 AA;  32125 MW;  9C1F22DF787FD49D CRC64;
     MAFMKKYLLP LLGLFLAYYY YSANEEFRPE MLQGKKVIVT GASKGIGKEI AFHLAKMGAH
     VVVTARSKET LQEVVAHCLK LGAASAHYIA GTMEDMTFAE QFVAKAGKLM GGLDMLILNH
     ITNASLMFFN NDIHHVRKEM EVNFLSYVVL TVAALPMLKQ SNGSIVVVSS LAGKIAHPLI
     APYSASKFAL DGFFSAIRKE HALTNVNVSI TLCVLGLIDT DTAMKEVSGK IDMKAAPKEE
     CALEIIKGGA LRQDEVYYGN LQWTPLLLGN PGKRLIEFLH LRKFDISKLV NN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024